Cushman & Wakefield Represents Deka Immobilien in US$320 Million Acquisition of Melbourne Office Tower
MELBOURNE, Australia--(BUSINESS WIRE)--Cushman & Wakefield (NYSE: CWK) represented German investor Deka Immobilien in the acquisition…
6 years ago
GNT Pharma Announces Positive Top-Line Results in a Phase II Study of Nelonemdaz for Acute Ischemic Stroke Patients Treated With Endovascular Thrombectomy
Safety and Tolerability Established Good and Excellent Functional Outcome Increased YONGIN, South Korea--(BUSINESS WIRE)--#AlzheimersDisease--GNT Pharma…
6 years ago
Black Lives Matter Tops Global Ranking of Activist Movements
2020 has seen a remarkable, global increase in grassroots movement activity, with concrete impact on…
6 years ago
Ari Retail POS Software Now Offering Retail Insight Integration
Ari's integration with Retail Insight brings the best of retail and accounting to your door.…
6 years ago
Results of the PROSPECT II Natural History Study Demonstrate High-Risk Plaques Identified by NIRS+IVUS Imaging are Linked to Future Coronary Events
PROSPECT ABSORB, a randomized substudy, showed treatment of high risk plaques with BVS is safe…
6 years ago
IoTize’s TapNLink Wins NFC Forum 2020 Award for Innovation
TapNLink wins with secure, intuitive NFC 3-Stroke connection for mobiles that eases configuration of HVAC…
6 years ago
CGTN: China Vows to Expand All-Around Opening-Up at Shenzhen SEZ’s 40th Anniversary
BEIJING--(BUSINESS WIRE)--China on Wednesday vowed to unswervingly expand the all-around opening-up of its economy as…
6 years ago
NTT DATA Places No. 3 on Prestigious IDC FinTech Ranking
2020 IDC FinTech Rankings Qualify IT Vendors Based on Revenues Generated in Financial Services Sector…
6 years ago
Nokia’s Revival: Is the Finnish Vendor Already Benefiting from Huawei’s Absence?
LONDON & BOSTON & TORONTO & NEW DELHI & BEIJING & TAIPEI & SEOUL--(BUSINESS WIRE)--Nokia…
6 years ago
Qihan Biotech Unveils its Program to Develop Immunologically Privileged Human Stem Cells for Allogeneic Cell Therapies
HANGZHOU, China--(BUSINESS WIRE)--Qihan Biotech, a leader in applying multiplexable genome editing technology to cell therapies…
6 years ago